Скачать с ютуб Cancer Immunotherapy: 2023 Research and a Look Ahead with Nina Bhardwaj, MD, PhD в хорошем качестве

Cancer Immunotherapy: 2023 Research and a Look Ahead with Nina Bhardwaj, MD, PhD

This year has been marked by significant advancements in personalized immunotherapies, technological innovations, predictive biomarkers, and initiatives to improve health equity and accessibility to clinical trials. To shed light on these remarkable developments, we spoke with Dr. Nina Bhardwaj, as part of our "Cancer Immunotherapy and You" patient education webinar series. Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. https://www.cancerresearch.org Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.